Funny how everyone loves Geert, then in one day, people start hating on him and so many new posters come out of the cracks to talk trash or nonsense. <br /> <br /> The situation with the company itself is unchanged (less funds though), so would everyone calm down. <br /> <br /> If this keeps up though, we're going to need another dilution next month. <br /> <br /> Last December they raised enough for 1 additional quarter and I mentioned we'd likely need another one, and given the price drop and the Covid-19 turmoil on the markets it is likely difficult to convince warrant holders to convert at the moment. <br /> <br /> I was expecting the strategy to be to get to results on the last raise, assuming Cel-Sci does have an understanding of the total number of events thus far, otherwise why only raise 1 quarter's worth of cash, but perhaps if ZSBiotech is correct then a new time-point of May 2020 has been put forward. Either-way a new raise pre-results is looking more likely now. I don't see why Cel-Sci doesn't open an ATM. They could take when they want at the higher market prices, especially as they are clearly going to need significantly more cash, pre and/or post-results. <br /> <br /> However yes we should still take it as good news that the trial is still ongoing. Either the drug is amazing, or there's been a big mess up with type of patient recruitment, but that shouldn't be the case. I don't buy the concern on drop-outs either as the IDMC ought to have mentioned something on that by now.